Benproperine phosphate - CAS 19428-14-9
Catalog: |
BB015047 |
Product Name: |
Benproperine phosphate |
CAS: |
19428-14-9 |
Synonyms: |
Blascorid; Pirexyl phosphate |
IUPAC Name: | 1-[1-(2-benzylphenoxy)propan-2-yl]piperidine;phosphoric acid |
Description: | Benproperine phosphate is a cough suppressant and an inhibitor of actin-related protein 2/3 complex subunit 2 (ARPC2). Benproperine phosphate also showed a significant anticancer effect on pancreatic cancer both in vitro and in vivo via the induction of autophagy-mediated cell death. |
Molecular Weight: | 407.44 |
Molecular Formula: | C21H27NO.H3O4P |
Canonical SMILES: | CC(COC1=CC=CC=C1CC2=CC=CC=C2)N3CCCCC3.OP(=O)(O)O |
InChI: | InChI=1S/C21H27NO.H3O4P/c1-18(22-14-8-3-9-15-22)17-23-21-13-7-6-12-20(21)16-19-10-4-2-5-11-19;1-5(2,3)4/h2,4-7,10-13,18H,3,8-9,14-17H2,1H3;(H3,1,2,3,4) |
InChI Key: | MCVUURBOSHQXMK-UHFFFAOYSA-N |
Boiling Point: | 433 °C at 760 mmHg |
Appearance: | White or almost white powder |
LogP: | 3.53990 |
Publication Number | Title | Priority Date |
TW-202019430-A | Pharmaceutical composition containing insoluble alkaline agent | 20180629 |
AU-2019293777-A1 | Pharmaceutical composition containing poorly-soluble basic medicine | 20180629 |
EP-3815688-A1 | Pharmaceutical composition containing poorly-soluble basic medicine | 20180629 |
KR-20210024541-A | Pharmaceutical composition containing poorly soluble basic drug | 20180629 |
US-2021290630-A1 | Pharmaceutical composition containing poorly-soluble basic medicine | 20180629 |
PMID | Publication Date | Title | Journal |
18800357 | 20090301 | Resonance light scattering study on the interaction of benproperine phosphate with eriochrome blue black R in the presence of sodium dodecylbenzene sulphonate and its analytical application | Luminescence : the journal of biological and chemical luminescence |
17763766 | 20070601 | [Nondestructive quantitative analysis of Cofrel medicines by improved partial least squares-NIR spectroscopy] | Guang pu xue yu guang pu fen xi = Guang pu |
9152562 | 19970301 | The nonnarcotic antitussive drug dimemorfan: a review | Clinical therapeutics |
Complexity: | 370 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 2 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 407.18616006 |
Formal Charge: | 0 |
Heavy Atom Count: | 28 |
Hydrogen Bond Acceptor Count: | 6 |
Hydrogen Bond Donor Count: | 3 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 407.18616006 |
Rotatable Bond Count: | 6 |
Topological Polar Surface Area: | 90.2 |
Undefined Atom Stereocenter Count: | 1 |
Undefined Bond Stereocenter Count: | 0 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Piperidines
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS